首页> 外文期刊>Drug Design, Development and Therapy >Soy polysaccharide as a novel superdisintegrant in sildenafil citrate sublingual tablets: preparation, characterization, and in vivo evaluation
【24h】

Soy polysaccharide as a novel superdisintegrant in sildenafil citrate sublingual tablets: preparation, characterization, and in vivo evaluation

机译:大豆多糖作为枸sil酸西地那非舌下片中的新型超级崩解剂:制备,表征和体内评价

获取原文
       

摘要

Abstract: Sildenafil citrate (SC), a drug used to treat erectile dysfunction, is available in tablet form but has three major problems. First, the drug displays inadequate aqueous solubility, which delays the onset of its action. Second, the drug undergoes extensive first-pass metabolism, resulting in a low (40%) bioavailability. Third, the gastrointestinal effects of SC include dyspepsia and a burning sensation. The aim of this research was to prepare SC as a sublingual tablet utilizing soy polysaccharide as novel superdisintegrant to mitigate the abovementioned problems. The solubility of SC in various hydrophilic carrier solutions was estimated in order to prepare the drug as a coprecipitate. Sublingual tablets were prepared and evaluated for hardness, friability, drug content, wetting time, water absorption ratio, in vitro dispersion time, dissolution rate, and stability study. The pharmacokinetic study of the tablets was carried out on healthy volunteers. The results indicated that the co-precipitation of SC with polyvinylpyrollidone K30 enhanced the solubility of SC by more than eight folds. The tablet contained 8% soy polysaccharide as a superdisintegrant and provided a wetting time of 25?seconds, and in vitro dispersion times of 55?seconds. The drug release was found to be 95.6%. The prepared SC sublingual tablet also exhibited a rapid onset of action, and its bioavailability was enhanced 1.68-fold compared with that of the marketed tablets. It can be concluded that SC sublingual tablet is a promising formulation that results in higher solubility, faster dispersion and onset of action, higher release rate, and higher systemic bioavailability.
机译:摘要:用于治疗勃起功能障碍的柠檬酸西地那非(SC)以片剂形式存在,但存在三个主要问题。首先,该药物显示出不足的水溶性,这延迟了其作用的开始。其次,该药物会经历大量的首过代谢,从而导致较低的生物利用度(40%)。第三,SC的胃肠道影响包括消化不良和烧灼感。这项研究的目的是制备SC作为舌下片剂,利用大豆多糖作为新型超级崩解剂来缓解上述问题。为了制备作为共沉淀的药物,估计了SC在各种亲水性载体溶液中的溶解度。制备舌下片剂并评估其硬度,脆性,药物含量,润湿时间,吸水率,体外分散时间,溶解速率和稳定性研究。在健康志愿者上进行了片剂的药代动力学研究。结果表明,SC与聚乙烯吡咯烷酮K30的共沉淀使SC的溶解度提高了八倍以上。该片剂含有8%的大豆多糖作为超级崩解剂,润湿时间为25秒,体外分散时间为55秒。发现药物释放为95.6%。所制备的SC舌下片剂还显示出起效快,并且其生物利用度与市售片剂相比提高了1.68倍。可以得出结论,SC舌下片剂是一种有前途的制剂,可导致更高的溶解度,更快的分散和起效,更高的释放速率和更高的全身生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号